| Name | MRT-2359 |
|---|
| Description | MRT-2359 is an orally active and potent degrader of GSPT1 with anti-tumor activity. MRT-2359 also inhibits the growth of resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells. MRT-2359 exhibits preferential activity in MYC-driven cell lines, such as N- and L-MYC high NSCLC and SCLC patient-derived xenografts (PDXs)[1]. |
|---|---|
| Related Catalog | |
| Target |
GSPT1[1] |
| References |
| Molecular Formula | C22H17F4N3O6 |
|---|---|
| Molecular Weight | 495.38 |